Results 91 to 100 of about 18,082 (276)

Non melanoma skin cancer pathogenesis overview [PDF]

open access: yes, 2018
(1)Background: Non-melanoma skin cancer is the most frequently diagnosed cancer in humans. The process of skin carcinogenesis is still not fully understood.
Bottoni Ugo   +3 more
core   +1 more source

Long‐Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real‐World Analysis

open access: yeseJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Introduction Ruxolitinib is a key therapeutic option for patients with myeloproliferative neoplasms. Its short‐term toxicity profile is well‐established, but long‐term safety data remains scarce. Methods We aimed to evaluate toxicity associated with long‐term exposure to ruxolitinib (defined as 3 years or longer) through a dual‐cohort ...
Alberto Blanco‐Sánchez   +8 more
wiley   +1 more source

A fluorescing spot on the temple: a helpful reminder for a detailed history and physical exam [PDF]

open access: yes, 2019
We discuss a woman with a history of non-melanoma skin cancer who presented with a new erythematous macule on her right temple. On examination with Wood lamp the well-demarcated macule fluoresced pink making neoplasm unlikely.
Neiner, Destiny   +3 more
core  

Swiss clinical practice guidelines on field cancerization of the skin. [PDF]

open access: yes, 2014
Actinic keratosis (AK) affects millions of people worldwide, and its prevalence continues to increase. AK lesions are caused by chronic ultraviolet radiation exposure, and the presence of two or more AK lesions along with photodamage should raise the ...
Anliker, M.   +12 more
core   +2 more sources

Contemporary management of actinic keratosis

open access: yesJournal of Dermatological Treatment, 2019
Actinic keratosis (AK) is a skin lesion characterized by itraepithelial keratinocyte dysplasia and molecular alterations shared with normal chronically sun-damaged skin and squamous cell carcinoma (SCC). AK can undergo spontaneous regression, stable existence, or malignant transformation to cutaneous SCC with progression rates to SCC ranging from 0% to
Michael A. Marchetti   +3 more
openaire   +4 more sources

Patient Perspectives of Quality Compared to Quantity of Life Regarding Orbital Exenteration

open access: yesOtolaryngology–Head and Neck Surgery, Volume 173, Issue 5, Page 1170-1181, November 2025.
Abstract Objective Orbital exenteration (OE) impacts patients cosmetically, functionally, and psychosocially. Eye‐sparing strategies with the advent of immunotherapy have developed the potential to avoid OE but may result in suboptimal oncologic outcomes and reduced survival.
Kalpesh Hathi   +3 more
wiley   +1 more source

White-light oblique-incidence diffuse reflectance spectroscopy for classification of in-vivo pigmented skin lesions [PDF]

open access: yes, 2007
A study of in-vivo classification of pigmented skin lesions using oblique-incidence diffuse reflectance spectroscopy is presented. Spatio-spectral data in the wavelength range from 455 to 765 nm are collected from 111 pigmented lesions including 10 ...
Duvic, Madeleine   +3 more
core  

Euphorbia-derived natural products with potential for use in health maintenance [PDF]

open access: yes, 2019
Euphorbia genus (Euphorbiaceae family), which is the third largest genus of angiosperm plants comprising ca. 2000 recognized species, is used all over the world in traditional medicine, especially in the traditional Chinese medicine. Members of this taxa
Adedoyin   +34 more
core   +4 more sources

Treatment considerations in actinic keratosis [PDF]

open access: yesJournal of the European Academy of Dermatology and Venereology, 2017
AbstractThe chronic skin condition actinic keratosis (AK) is characterized by the formation of keratotic lesions of variable thickness that are poorly delimited. AK occurs on areas of the skin that have had long‐term exposure to the sun or UV radiation.
openaire   +3 more sources

Simulated daylight vs. conventional PDT for clinical superficial BCC: A randomized controlled trial

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 11, Page 1997-2004, November 2025.
In this single‐centre, non‐inferiority, randomized controlled trial, SDL‐PDT (n = 95 lesions) was less effective than C‐PDT (n = 98 lesions) in treating superficial basal cell carcinoma One‐year clearance rates: 61.3% with SDL‐PDT versus 91.8% with C‐PDT (p < 0.001).
Alexandra Sjöholm   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy